FWCM
IBB icon

Ferguson Wellman Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Ferguson Wellman Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Sell
6,013
-170
-3% -$29.2K 0.01% 221
2026
Q1 		$1.04M Sell
6,183
-182
-3% -$31.1K 0.01% 212
2025
Q4 		$1.07M Sell
6,365
-471
-7% -$76.5K 0.02% 179
2025
Q3 		$987K Buy
6,836
+108
+2% +$14.7K 0.02% 187
2025
Q2 		$851K Sell
6,728
-1,650
-20% -$203K 0.02% 193
2025
Q1 		$1.07M Sell
8,378
-460
-5% -$62.4K 0.02% 181
2024
Q4 		$1.17M Sell
8,838
-330
-4% -$46.4K 0.02% 174
2024
Q3 		$1.33M Sell
9,168
-285
-3% -$41.2K 0.03% 174
2024
Q2 		$1.3M Sell
9,453
-685
-7% -$91.4K 0.03% 164
2024
Q1 		$1.39M Sell
10,138
-735
-7% -$100K 0.03% 162
2023
Q4 		$1.48M Sell
10,873
-646
-6% -$78.8K 0.03% 158
2023
Q3 		$1.41M Sell
11,519
-930
-7% -$118K 0.03% 149
2023
Q2 		$1.58M Sell
12,449
-35
-0.3% -$4.55K 0.04% 154
2023
Q1 		$1.61M Sell
12,484
-85
-0.7% -$11.1K 0.04% 151
2022
Q4 		$1.65M Buy
12,569
+3,201
+34% +$414K 0.04% 154
2022
Q3 		$1.1M Sell
9,368
-881
-9% -$109K 0.04% 153
2022
Q2 		$1.21M Sell
10,249
-1,935
-16% -$230K 0.04% 156
2022
Q1 		$1.59M Sell
12,184
-789
-6% -$103K 0.05% 151
2021
Q4 		$1.98M Sell
12,973
-70
-0.5% -$10.8K 0.06% 138
2021
Q3 		$2.11M Sell
13,043
-260
-2% -$43.8K 0.07% 136
2021
Q2 		$2.18M Sell
13,303
-3,350
-20% -$516K 0.07% 132
2021
Q1 		$2.51M Sell
16,653
-7,014
-30% -$1.11M 0.09% 114
2020
Q4 		$3.59M Sell
23,667
-4,873
-17% -$696K 0.09% 153
2020
Q3 		$3.87M Sell
28,540
-3,315
-10% -$450K 0.11% 136
2020
Q2 		$4.36M Sell
31,855
-635
-2% -$80.9K 0.13% 123
2020
Q1 		$3.5M Sell
32,490
-12,140
-27% -$1.4M 0.13% 129
2019
Q4 		$5.38M Buy
44,630
+12,213
+38% +$1.36M 0.16% 121
2019
Q3 		$3.23M Sell
32,417
-2,910
-8% -$305K 0.1% 137
2019
Q2 		$3.85M Sell
35,327
-17,930
-34% -$1.91M 0.13% 127
2019
Q1 		$5.95M Sell
53,257
-30,664
-37% -$3.36M 0.2% 107
2018
Q4 		$8.09M Buy
83,921
+70,941
+547% +$7.53M 0.31% 83
2018
Q3 		$1.58M Buy
12,980
+245
+2% +$28.9K 0.05% 173
2018
Q2 		$1.4M Sell
12,735
-150
-1% -$16K 0.05% 181
2018
Q1 		$1.38M Hold
12,885
– – 0.05% 184
2017
Q4 		$1.38M Sell
12,885
-189
-1% -$20.2K 0.05% 179
2017
Q3 		$1.45M Hold
13,074
– – 0.05% 173
2017
Q2 		$1.35M Sell
13,074
-390
-3% -$38.4K 0.05% 172
2017
Q1 		$1.32M Sell
13,464
-3,606
-21% -$345K 0.05% 173
2016
Q4 		$1.51M Buy
17,070
+5,070
+42% +$461K 0.06% 167
2016
Q3 		$1.16M Hold
12,000
– – 0.05% 161
2016
Q2 		$1.03M Buy
+12,000
New +$1.08M 0.04% 169

Other funds holding IBB

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Ferguson Wellman Capital Management's IBB Position: Q2 2026 in Review

Ferguson Wellman Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 2.7% in Q2 2026, selling an estimated $29.2K and leaving 6,013 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #221.

Ferguson Wellman Capital Management first reported a position in IBB in Q2 2016 and has held it in 41 quarters since. The position peaked at $8.09M in Q4 2018. 320 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Ferguson Wellman Capital Management held 6,013 shares of iShares Biotechnology ETF worth $1.14M as of Q2 2026.
  • Ferguson Wellman Capital Management sold 170 iShares Biotechnology ETF shares in Q2 2026, an estimated $29.2K.
  • iShares Biotechnology ETF made up 0.01% of Ferguson Wellman Capital Management's portfolio in Q2 2026, its #221 holding.
  • Ferguson Wellman Capital Management first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 41 quarters since.
  • Ferguson Wellman Capital Management's iShares Biotechnology ETF position peaked at $8.09M in Q4 2018.
  • 320 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Ferguson Wellman Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.